Clinical & Diagnostic
Addressing the Dengue Crisis in Southeast Asia: Insights from Prof. Tikki Pangestu and Prof. Lulu Bravo
In this exclusive interview, BioPharma APAC engage with two distinguished experts in the field of infectious diseases and immunization: Prof. Tikki Pangest...
December 04, 2023 | News
Thermo Fisher and Project HOPE Collaborate for Health Equity in Sub-Saharan Africa's HIV-Positive Youth.
Thermo Fisher Scientific Inc., the world leader in serving science, and Project HOPE, a leading global health and humanitarian organization, tod...
December 04, 2023 | News
China Pharma Completes Third-Party Testing for Dry Eye Therapeutic Device
According to a disclosure by the Shanghai Public Health Clinical Center on June 6, 2023, an epidemiological survey of DED showed that approximately 34...
November 30, 2023 | News
AbbVie Provides FDA and EMA Updates on Epcoritamab for Lymphoma Treatment
Updates are supported by data from the Phase 1/2 EPCORE™ NHL-1 clinical trial AbbVie announced updates from the U...
November 29, 2023 | News
Gilead Sciences Funds HIV Projects in Asia Pacific with $1.5M
–2023 Gilead Asia Pacific Rainbow Grant Funding Will Support 40 Projects In 2024-2025 To Reduce HIV Stigma And Improve Equity Across Asia Pacific &nd...
November 29, 2023 | News
Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
Astellas Pharma Inc. announced that the companies received an approval by the U.S. Food and Drug Administration (FDA) of a supplemental New Drug Appl...
November 27, 2023 | News
Boehringer Ingelheim broadens immuno-oncology portfolio with T3 Pharma acquisition
Despite the significant transformation of the cancer treatment landscape by immunotherapies, long-term remissions only occur in 15-20% of cancer patients. ...
November 27, 2023 | News
Simcere and Connect ink exclusive deal for autoimmune drug Rademikibart.
Pursuant to the Agreement, Simcere obtains the exclusive rights in the development, manufacturing, and commercialization of Rademikibart for all indication...
November 24, 2023 | News
BeiGene and Ensem Therapeutics Partner to Advance CDK2 Inhibitor
“We are committed to developing novel molecules with the potential to transform the therapeutic landscape for cancer patients, and this partnership f...
November 23, 2023 | News
Ark Biopharma's AK0610 Receives NMPA IND Approval for RSV Neutralizing Antibody
It is anticipated to protect infants throughout an entire RSV season. ArkBio licensed the drug's intellectual properties from the Institute of Microb...
November 23, 2023 | News
Porton Advanced and Ascle Therapeutics Form Strategic Partnership for NK Cell Applications in Cancer Prevention, Beauty, and Anti-aging
Porton Advanced is committed to providing end-to-end gene and cell therapy CDMO services, covering fields such as plasmids, cell therapy, gene therapy, and...
November 21, 2023 | News
CU Medicine Innovates MOZAICTM Microbiome Tech for Fecal Microbiota Transplants
Clostridioides difficile infection (CDI) is a common hospital-acquired infection worldwide. Recurrence and mortality rates have been reported to be up...
November 17, 2023 | News
Kite Expands Collaboration with Arcellx, Exercises Option for ACLX-001 in Multiple Myeloma
-- The companies expand the scope of their existing collaboration for CART-ddBCMA to include lymphomas -- -- Kite exercises option to Arcellx’s ARC-...
November 16, 2023 | News
Foundation Medicine Collaborates with Pierre Fabre on Non-Small Cell Lung Cancer Diagnostics
The companies will work collaboratively to seek the regulatory approval for Foundation Medicine assays which detect mutations including BRAFV600E to i...
November 16, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
